Cellular Technical Services Co. Inc. (fka CTSC)

[linuspop]

delete

[stanley01]

BRIG_88 on LGFT

Volume seems to be pretty high in comparison to prior trading days.... plus we are only 15 minutes into trading. With how thin L2 is, I think we might see a huge pop. It seems like the MMs are stacked at $11!!

[BRIG_88]

yeah i have it on my streamer...has a wide spread and no volume to speak of so far....looks like he controls another one.....OPK.....that one the clock is ticking on...phase III trials ongoing.....i expect it to monster.....BRIG

[stanley01]

LGFT WOW FROST TO BUY 51% STAKE!!!!

BRIG_88 ANOTHER FROST STOCK HAS APPEARED LGFT-- check this baby out!!! I see maybe even $10 today. Level 2 is extremely thin!! Here is the PR----

Longfoot Communications Corp Announces Proposed Sale of 51% of the Company
Tuesday October 23, 4:00 pm ET
Also intends to shed current low power television transmission business

LOS ANGELES--(BUSINESS WIRE)--Longfoot Communications Corp. (OTCBB:LGFT - News) today announced that it entered into a Stock Purchase Agreement with a small group of investors, led by Dr. Phillip Frost. The agreement provides for Longfoot to implement a one-for-three reverse stock split, increase its authorized shares, and for Longfoot to sell an aggregate of 1,698,212 post-reverse split unregistered shares, or 51% of the post-reverse split outstanding shares, to the investor group. The purchase price is expected to be an amount equal to approximately net cash of the company on the closing date after deducting liabilities and costs, including costs and expenses of this transaction. Longfoot expects that closing of the transactions will occur on or around December 7, 2007.

Dr. Frost is the Chairman and Chief Executive Officer of Opko Health, Inc., a specialty healthcare company focused on the treatment, diagnosis and prevention of ophthalmic diseases. Previously, Dr. Frost founded IVAX Corporation and served as Chairman of the Board of Directors and Chief Executive Officer of IVAX from 1987 until its sale to Teva Pharmaceuticals Industries Ltd., in January 2006. Dr. Frost has served as Vice Chairman of the Board of Directors of Teva since the completion of the acquisition of IVAX.

As part of this transaction the board of directors of Longfoot has agreed to dispose of the current low power television operations of the company. Arthur Lyons, Chief Executive Officer of Longfoot Communications Corp., stated, “We believe the prominence of the investor group should allow Longfoot Communications Corp. to broaden its opportunities with respect to Longfoot’s future business.” The reverse share split, disposition of operating business and assets, and certain other matters contemplated within the agreement among the parties are subject to stockholder approval. This release does not constitute a solicitation of proxies with respect to such approvals.

About Longfoot Communications Corp:

Longfoot Communications is engaged in acquiring, developing and operating Low Power Television Stations (“LPTV”) and radio stations. Since commencing operations in late 2004 Longfoot Communications has acquired three LPTV construction permits including the permit in Winslow, Arizona which has been constructed and is currently broadcasting. Longfoot Communications has not commenced constructing LPTV stations or radio stations with the other two construction permits but is evaluating their economic viability and may proceed with their construction in the near future if economic conditions are deemed to be favorable. Construction permits are an exclusive right granted by the Federal Communications Commission to construct a new LPTV or radio broadcast facility.

Forward Looking Statements:

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the pending matters and transactions considered by the Longfoot may not proceed as contemplated, and by all other matters specified in Longfoot’s filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. Longfoot does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Longfoot’s filings with the Securities and Exchange Commission, including its most recent periodic report.



Contact:
Longfoot Communications
Arthur Lyons, 310-385-9631

--------------------------------------------------------------------------------
Source: Longfoot Communications Corp.

[BRIG_88]

rocking....now a double from original entry.....BRIG

[BRIG_88]

another nice day on CTSC....BRIG

[BRIG_88]

still climbing.....Dr. Frost bought more shares....BRIG

[BRIG_88]

making a nice move today....volume still light but float is very low....BRIG

[BRIG_88]

September 5, 2007 - 7:50 AM EST


Cellular Technical Services Company, Inc. Acquires SafeStitch LLC; Company to Develop and Market Endoscopic and Minimally Invasive Surgery Devices

SafeStitch LLC, a privately owned medical device company developing endoscopic and minimally invasive surgery devices, was acquired yesterday by Cellular Technical Services Company, Inc. (OTCBB: CTSC), a publicly-traded company with no active operations. SafeStitch is headquartered in Miami, Florida, and has a research and development office in Omaha, Nebraska. It intends to apply to have its shares listed on the American Stock Exchange (AMEX).

SafeStitch’s product portfolio includes a device for endoscopic bariatric surgery (obesity surgery) and endoscopic repair of gastroesophageal reflux disorder (GERD), as well as an endoscopic device for excision and diagnosis of Barrett’s esophagus. The company also plans to market a novel standard bite block, as well as the first airway bite block, to be used during endoscopy, and is pioneering the Smart Dilator for esophageal strictures. SafeStitch also intends to develop products for hernia repair and natural orifice transluminal endoscopic surgery (NOTES).

Dr. Phillip Frost, former chief executive officer and chairman of IVAX Corporation and Dr. Jane Hsiao, former vice-chairman and chief technical officer of IVAX Corporation, along with Dr. Charles J. Filipi, Professor of Surgery at Creighton University Medical School, and Jeffrey G. Spragens, one of the founders of North American Vaccine Corporation, are the principal investors in SafeStitch LLC. Dr. Hsiao will become the chairman of the board; Mr. Spragens, the chief executive officer and president; Dr. Stewart B. Davis, formerly of Innovia LLC, the chief operating officer; and Dr. Filipi, the medical director. Steven D. Rubin, former senior vice president and general counsel of IVAX Corporation, will serve on its Board of Directors.

As part of the transaction, The Frost Group, a private equity group headed by Dr. Frost, along with Mr. Spragens, have agreed to provide the company with a $4 million line of credit. Proceeds from this line of credit, along with the approximately $3 million of cash held by Cellular Technical Services Company,Inc., are expected to be sufficient to fund the company’s continued development and upcoming clinical trials.

“There are major opportunities in endoscopic and minimally invasive surgery for improved therapies, and we are optimistic that SafeStitch will develop significant products for treatment of obesity, GERD, Barrett’s esophagus and more,” said Dr. Frost. “Dr. Filipi brings to SafeStitch many years of experience and expertise in endoscopic and surgical treatment as well as development of multiple medical devices that have achieved significant commercial success. We have an extraordinary product pipeline which will allow our company to help many patients. Many of our devices have been developed in conjunction with Creighton University, where Dr. Filipi is a professor, and we will continue to collaborate with Creighton.”

[Tina]

Nice green day here BRIG :)

[BRIG_88]

This is another Dr. Frost backed company...the billionaire with the Midas touch......i'm accumulating this as well at OPK.......BRIG

[kewlassht]

wow this is way under radar still, lets gooo CTSC

[stanley01]

CTSC- Philip Frost Gains Control! Oh Baby!

Cellular Technical Services Company, Inc. Announces Agreement to Combine with SafeStitch LLC
Wednesday July 25, 1:07 pm ET

NEW YORK--(BUSINESS WIRE)--Cellular Technical Services Company, Inc. ("CTS") (OTC BB: CTSC - News) announced today that it has entered into a Share Transfer, Exchange and Contribution Agreement (the "Agreement") with SafeStitch LLC and its members whereby SafeStitch members will transfer all of their membership interests to CTS in consideration for an aggregate of 11,256,369 newly issued shares of common stock of CTS. As a result of the transaction, the members of SafeStitch will receive approximately 70% of the issued and outstanding shares of CTS. Dr. Jane Hsaio and Dr. Philip Frost, each a director of CTS, are also members of SafeStitch LLC.

As part of and after the closing of the transaction, the Frost Group, an entity controlled by Dr. Philip Frost, has agreed to provide a line of credit to CTS of up to $4,000,000 and will receive warrants to acquire 805,521 shares of the common stock of CTS, equal to 5% of CTS shares on a fully diluted basis after giving effect to the Agreement.

A fairness opinion was rendered prior to approval of the Agreement by CRA International, Inc., an independent New York Stock Exchange business valuation firm retained by CTS and its independent directors.

Upon the closing of the transactions contemplated by the Agreement, all current CTS directors except Dr. Hsaio and Richard C. Pfenniger will resign and new directors will be appointed and CTS will be re-named SafeStitch Medical Devices. It is expected that CTS will be headquartered in Miami, Florida, with a research and development center in Omaha, Nebraska. Subject to the conditions in the Agreement being satisfied, the transaction is expected to close by the end of 2007.

About CTS and SafeStitch

CTS has no current business. As such, the Company's principal business purpose at this time is to locate and consummate a merger or acquisition with a private entity. Previously it was engaged in marketing and distributing prepaid long-distance phone-card products, prepaid wireless phones and phone-cards.

SafeStitch LLC is a privately owned early-stage endoscopic and minimally invasive surgery medical device company with a product portfolio that includes a device for endoscopic bariatric surgery and endoscopic repair of gastroesophageal reflux disorder (GERD), as well as an endoscopic device for excision of Barrett's esophagus. SafeStitch is also seeking to develop new techniques for hernia repair and natural orifice transesophageal surgery as well as planning to market novel standard bite block devices and the first Smart (Safety) Dilator for esophageal strictures.

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), regarding product development efforts and other non-historical facts about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in our filings with the Securities and Exchange Commission ("SEC"), which are available at the SEC's website http://www.sec.gov, as well as risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. We do not undertake any obligation to update forward-looking statements and revise statements contained in these materials based on new information or otherwise.



Contact:
Cellular Technical Services Company, Inc.
Steve Katz, Chairman and CEO
516-887-0700

--------------------------------------------------------------------------------
Source: Cellular Technical Services Company, Inc.

[amohedas]

Looking to pick some of this up.

EXEG and NIMU doing well for me.

[kewlassht]

Hes invested in CELL VINE, thats what i think will come here and MERGE with CTSC, all calls and emails to them have been unresponded, i like the action this been getting recently, slowly creeping. CELL vine boosts signals basically anywhere and is backed by some heavy hitters in Israel and all have close ties to Frost. ANy other reason he would buy CTSC if not to bring Cellvine public??

"Frost is also finding other deals in Israel, which he describes as an "extremely user-friendly environment for new businesses," with good general tax rates, special tax holidays for new manufacturing and matching government grants for scientific firms.

He's a general partner in an Israel venture capital fund and has purchased a stake in a young Israeli company, Cell Vine, which enhances signals for cellphones by using small boxes to boost signals in hard-to-reach places, such as large buildings or subways. He may eventually help Cell Vine go public by folding it into a U.S. shell, as he did with Protalix."

[up all night]

interesting shell very low floater
4,586,758 Common Shares were outstanding as of April 2, 2007

im sure Frost has a plan for this one. Might need a forward split to really get it liquid.

[Bitra21]

no visitors...ok..

[Bitra21]

Frost company and quiet... huh..